SCHEMBL11992123

SCHEMBL11992123

c1ccc(-c2ccc(-c3c4c(c(-c5ccc(-c6ccccc6)cc5)c5ccccc35)-c3ccc(-c5cccc(-c6ccccn6)n5)c5cccc-4c35)cc2)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 5/20 0.46
SMN1; SMN2 Q16637 5/20 0.46
KDM4E B2RXH2 4/20 0.46
TP53 P04637 4/20 0.46
CCR1 P32246 3/20 0.46
CCR5 P51681 3/20 0.46
CCR8 P51685 3/20 0.46
MAPK1 P28482 3/20 0.46
ALPL P05186 1/20 0.46
HSP90AA1 P07900 1/20 0.46
ALPI P09923 1/20 0.46
ALPG P10696 1/20 0.46
ALOX15 P16050 1/20 0.46
HTT P42858 1/20 0.46
TDP1 Q9NUW8 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
RAB9A P51151 5/20 0.38
HPGD P15428 4/20 0.38
HSD17B10 Q99714 3/20 0.38
ALDH1A1 P00352 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11992079 0.97 SMN1; SMN2 (0.49) LMNASMN1; SMN2KDM4ETP53CCR1
SCHEMBL11992078 0.96 SMN1; SMN2 (0.47) LMNASMN1; SMN2KDM4ETP53CCR1
SCHEMBL11992094 0.93 LMNA (0.44) LMNASMN1; SMN2KDM4ETP53CCR1
SCHEMBL11992082 0.93 LMNA (0.44) LMNASMN1; SMN2KDM4ETP53CCR1
SCHEMBL11992074 0.92 SMN1; SMN2 (0.46) LMNASMN1; SMN2KDM4ETP53CCR1
SCHEMBL11992088 0.91 SMN1; SMN2 (0.43) LMNASMN1; SMN2KDM4ETP53CCR1
SCHEMBL11992306 0.91 LMNA (0.45) LMNASMN1; SMN2KDM4ETP53CCR1
SCHEMBL11992086 0.91 LMNA (0.45) LMNASMN1; SMN2KDM4ETP53CCR1
SCHEMBL11992241 0.90 SMN1; SMN2 (0.42) LMNASMN1; SMN2KDM4ETP53CCR1
SCHEMBL11992126 0.90 KDM4E (0.44) LMNASMN1; SMN2KDM4ETP53CCR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9273002-B2 Benzo[k]fluoranthene derivative and organic electroluminescence device containing the same IDEMITSU KOSAN CO., LTD. (JP) 2016-03-01 US disclosed
US-20120211743-A1 BENZO[k]FLUORANTHENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE DEVICE CONTAINING THE SAME IDEMITSU KOSAN CO., LTD. (JP) 2012-08-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120211743-A1 BENZO[k]FLUORANTHENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE DEVICE CONTAINING THE SAME KCNJ2, KCNE1, KCNK2 LMNA 1575/4885SMN1; SMN2 1403/4885KDM4E 764/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.